Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can smartwatches and habit coaching keep seniors Frailty-Free?

NCT ID NCT07112352

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether smart devices and a habit-coaching app can help older adults (65+) stay active and healthy. Thirty participants will use a smartwatch and sleep mat with either a personalized coaching app or a standard app, or just receive an education leaflet. The goal is to see if this approach is practical and acceptable, not yet to prove it works.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Smart devices (smartwatch and sleep mat) with a 'Healthy Habits' app for coaching and data feedback
What this could lead to
If successful, this could show that digital tools help older adults adopt healthier habits, potentially reducing frailty.
What could go wrong
This is a small feasibility study with only 30 participants, so results may not apply widely. The intervention is short-term and may not lead to lasting changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * • Older adults (age ≥65) * Community-dwelling Adults living at home * Living within the London boroughs * Willing to engage in an exercise programme * On at least one medication * Pre-frail on Edmonton-AC and/or FRAIL and PRISMA \< 3 * Clinically assessed to have Fried 1-3 (this is completed at baseline assessment) * Has the capacity to provide informed consent * Able to speak and understand written English Exclusion Criteria: * • Adults less than 65 years old * Living outside the London boroughs * Living in a nursing home or hospitalised or hospice * Not taking any medication (indicating robust frailty status) * Significant cognitive impairment due to concerns that cognitive impairment and its causes presents different barriers to engagement and participation with sensors and intervention * Individuals with severe limitations in activities of daily living which would prevent active participation in the assessments, interfere with participation in the physical exercise programme * Being unable to safely engage in the exercise component for other health-related reasons such as Musculoskeletal or neurological disorders that impair gait speed and balance as these are key outcome metrics * Progressive or severe medical illness e.g. acute myocardial infarction in the last 3 months, unstable angina, severe aortic stenosis, uncontrolled orthostatic hypotension, recent bone fracture in the last 3 months, having a life expectancy of less than 24 months, requiring palliative care within the following two years, three or more hospitalisations in the last year * Moderate - Severe Depression, Psychiatric disorders which may interfere with their participation in the study * Being treated for active cancer * Unstable medical conditions or where clinical optimisation required e.g. uncontrolled diabetes. * Participating in other clinical studies * Unable to participate for 6 months in the study (with 28 days allowed to be away from home) * Unable to speak or understand written English

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Digital health intervention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Frailty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Helix Centre, Institute of Global Health Innovation, Department of Surgery and Cancer, Imperial College London

    London, W2 1NY, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.